138 related articles for article (PubMed ID: 28964817)
1. ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema.
Nojiri M; Mizuno S; Nishiki K; Kato R; Nakagawa K; Oikawa T; Iguchi M; Osanai K; Ishizaki T; Toga H
Pulm Pharmacol Ther; 2018 Feb; 48():80-87. PubMed ID: 28964817
[TBL] [Abstract][Full Text] [Related]
2. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
[TBL] [Abstract][Full Text] [Related]
3. Beta2-adrenergic receptor polymorphisms as a determinant of preferential bronchodilator responses to β2-agonist and anticholinergic agents in Japanese patients with chronic obstructive pulmonary disease.
Konno S; Makita H; Hasegawa M; Nasuhara Y; Nagai K; Betsuyaku T; Hizawa N; Nishimura M
Pharmacogenet Genomics; 2011 Nov; 21(11):687-93. PubMed ID: 21881540
[TBL] [Abstract][Full Text] [Related]
4. UGT1A1*28 is associated with greater decrease in serum K⁺ levels following oral intake of procaterol.
Yokoe N; Yamaguchi E; Nishimura M; Tanaka H; Takahashi A; Baba K; Gosho M; Okada S
J Asthma; 2015 Apr; 52(3):240-5. PubMed ID: 25171434
[TBL] [Abstract][Full Text] [Related]
5. CT scanning-based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease.
Kim WJ; Oh YM; Sung J; Lee YK; Seo JB; Kim N; Kim TH; Huh JW; Lee JH; Kim EK; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Kwon SY; Lee SD
Respir Med; 2009 Jan; 103(1):98-103. PubMed ID: 18789663
[TBL] [Abstract][Full Text] [Related]
6. Beta
Hussein MH; Sobhy KE; Sabry IM; El Serafi AT; Toraih EA
Adv Med Sci; 2017 Mar; 62(1):193-201. PubMed ID: 28327457
[TBL] [Abstract][Full Text] [Related]
7. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
[TBL] [Abstract][Full Text] [Related]
8. Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.
Nielsen AO; Jensen CS; Arredouani MS; Dahl R; Dahl M
COPD; 2017 Aug; 14(4):451-460. PubMed ID: 28506092
[TBL] [Abstract][Full Text] [Related]
9. Association Between ADRB2 Genetic Polymorphisms and the Risk of Chronic Obstructive Pulmonary Disease: A Case-Control Study in a Chinese Population.
Zhao H; Wu X; Dong CL; Wang BY; Zhao J; Cao XE
Genet Test Mol Biomarkers; 2017 Aug; 21(8):491-496. PubMed ID: 28753063
[TBL] [Abstract][Full Text] [Related]
10. Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.
Bandaru S; Akka J; Marri VK; Alvala M; Ponnala D; Mundluru HP
Inflammation; 2015 Dec; 38(6):2146-55. PubMed ID: 26071206
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis.
Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD
BMC Pulm Med; 2012 Sep; 12():50. PubMed ID: 22950544
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma.
Taylor DR; Epton MJ; Kennedy MA; Smith AD; Iles S; Miller AL; Littlejohn MD; Cowan JO; Hewitt T; Swanney MP; Brassett KP; Herbison GP
Am J Respir Crit Care Med; 2005 Sep; 172(6):700-3. PubMed ID: 15976384
[TBL] [Abstract][Full Text] [Related]
13. A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients.
Yelensky R; Li Y; Lewitzky S; Leroy E; Hurwitz C; Rodman D; Trifilieff A; Paulding CA
Pharmacogenomics J; 2012 Dec; 12(6):484-8. PubMed ID: 22158330
[TBL] [Abstract][Full Text] [Related]
14. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.
Ito I; Nagai S; Handa T; Muro S; Hirai T; Tsukino M; Mishima M
Am J Respir Crit Care Med; 2005 Dec; 172(11):1378-82. PubMed ID: 16126934
[TBL] [Abstract][Full Text] [Related]
16. Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome.
Xie M; Wang W; Dou S; Cui L; Xiao W
Int J Chron Obstruct Pulmon Dis; 2016; 11():953-61. PubMed ID: 27226711
[TBL] [Abstract][Full Text] [Related]
17. Genetic association analysis of COPD candidate genes with bronchodilator responsiveness.
Kim WJ; Hersh CP; DeMeo DL; Reilly JJ; Silverman EK
Respir Med; 2009 Apr; 103(4):552-7. PubMed ID: 19111454
[TBL] [Abstract][Full Text] [Related]
18. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
19. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.
Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD
Clin Physiol Funct Imaging; 2012 Jan; 32(1):12-8. PubMed ID: 22152074
[TBL] [Abstract][Full Text] [Related]
20. A functional SNP upstream of the
Li JX; Fu WP; Zhang J; Zhang XH; Sun C; Dai LM; Zhong L; Yu L; Zhang YP
Int J Chron Obstruct Pulmon Dis; 2018; 13():917-925. PubMed ID: 29588580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
